BSX was featured in a Barron’s article calling medical-device stocks undervalued, sparking discussion on r/ValueInvesting.
A John Neff low-P/E screen ranked BSX as the most attractive among several medical-tech companies.
The ticker saw 90 comments and 122 upvotes across 6 posts, with a slightly positive sentiment score of 0.15.
Boston Scientific Corp. (![]()
Value Investing Spotlight
The bulk of the discussion originated in r/ValueInvesting, where a post sharing a Barron’s article titled “Medical-Device Stocks Are in the Bargain Bin. 6 to Buy” garnered 70 upvotes and 59 comments. The article argued that fears over slowing healthcare utilization are overblown and that the AI boom has diverted attention from a sector trading at attractive valuations. Among the six stocks highlighted was ![]()
A second r/ValueInvesting post applied John Neff’s low-P/E investment method to a list of medical-tech companies. The analysis calculated a Total Return Ratio (TRR) for each stock and compared it to the S&P 500’s TRR. The conclusion: ![]()
Broader Portfolio Mentions
Beyond dedicated value discussions, ![]()
Subscribe to Tendie.bot for more market recaps.
